Thursday, October 23, 2014
Inquirer Daily News

Archive: May, 2013

Organize health care as if it was war

Wednesday, May 29, 2013, 6:00 AM
Does the private control of drug development and health care in general bestow better health and prosperity on Americans? For people in the C-suites, their bluestocking shareholders and some others, it undoubtedly does. For most Americans, it doesn't appear to work so well. Earlier this year the... Read more

OTC drugs that are quite different might share the same name

Wednesday, May 22, 2013, 6:05 AM
You may find it hard to believe, but FDA has no say in how many over-the-counter drugs are named. That’s a great help to companies who want to market their drugs but it’s a problem for those of us concerned about drug safety. OTC users sometimes fall victim to a potentially dangerous situation... Read more

Can Pharma handle pricing for value in this country?

Tuesday, May 21, 2013, 10:05 AM
All sectors in the health care business face major turning points within the next three years. This means the pharmaceutical industry and other manufacturers, together with providers such as physicians and hospitals, will operate in a different environment by the end of this decade. The important... Read more

How to prevent yourself from getting the wrong prescription

Thursday, May 16, 2013, 9:35 AM
Occasionally, things go wrong when prescriptions are being prepared at the pharmacy. For example, one person's medicine may be placed into a bag that is labeled with someone else's name. Or a label prepared for a prescription may be mistakenly placed on a bottle containing another person's medicine... Read more

Pharmas made less money but bought their own stock

Monday, May 13, 2013, 9:27 AM
Did anyone in Big Pharma post improved results for the first quarter? Pfizer, Merck, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Sanofi and Novartis (the last two in their pharmaceutical operations) all generated lower sales this past quarter, compared to the same period last year. Some companies... Read more

Diluted chemotherapy reaches 1,200 patients in error

Thursday, May 9, 2013, 12:10 PM
Nearly 1,200 patients in Canada received lower doses of their cancer drugs as a result of poor communication between a compounding pharmacy supplier and several hospitals that utilized the service. The drugs were cyclophosphamide and gemcitabine, used as part of a regimen for breast and lung cancer... Read more

Feds again go after Pharma, with a couple of twists

Tuesday, May 7, 2013, 10:50 AM
Last week the US Justice Department filed suit against Novartis that essentially accuses the company of bribing physicians with lavish dinners, trips and speaking fees so they would prescribe the company's drugs. The suit alleges, "In many instances Novartis made payments to doctors for purported... Read more
About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Also on Philly.com:
Stay Connected